[Guidelines in clinical immunohematology].
In order to take into account the improvement of the knowledge, technologies, automation and computerization in immuno-haematology, the French national regulatory service have redefined the way to complete immunohaematology tests and their links to the blood component distribution. We describe these modalities for each test considering three questions "What?", "When?" and "How?".
Chiaroni
J
J
EFS Provence-Alpes-Provence, 149, boulevard Baille, 13392 cedex 5, Marseille, France. jacques.chiaroni@efs.sante.fr <jacques.chiaroni@efs.sante.fr>
D000017:ABO Blood-Group System / Q000276:immunology*; D001781:Blood Component Removal / Q000592:standards*; D001787:Blood Group Incompatibility / Q000276:immunology / Q000517:prevention & control; D001803:Blood Transfusion / Q000592:standards*; D005602:France; D017408:Guidelines as Topic; D006405:Hematology / Q000592:standards*; D006801:Humans; D011785:Quality Assurance, Health Care
D000017:ABO Blood-Group System